COMPARISON OF PARATHYROIDECTOMIES WITH PARICALCITOL OR CINACALCET FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS

被引：0
|
作者：
Walton, Surrey M. [1 ]
Schumock, Glen T. [1 ]
Lee, Todd A. [1 ]
Marx, Steven E. [2 ]
Audhya, Paul [2 ]
Andress, Dennis L. [2 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2009年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
222
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [41] The Clinical Effect of Paricalcitol Treatment on Hemodialysis Patients with Secondary Hyperparathyroidism and the Influence of Abdominal Aortic Calcification
    Liu, Yin
    Yang, Tao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 221 - 222
  • [42] Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients
    Wacharee Seeherunvong
    Obioma Nwobi
    Carolyn L. Abitbol
    Jayanthi Chandar
    José Strauss
    Gastón Zilleruelo
    Pediatric Nephrology, 2006, 21 : 1434 - 1439
  • [43] Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism
    Kyritsis, I.
    Gombou, A.
    Griveas, I.
    Agroyannis, L.
    Retsa, K.
    Agroyannis, B.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (08): : 742 - 744
  • [44] PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
    Akizawa, Tadao
    Kurita, Noriaki
    Mizobuchi, Masahide
    Fukagawa, Masafumi
    Onishi, Yoshihiro
    Yamaguchi, Takuhiro
    Ellis, Alan R.
    Fukuma, Shingo
    Brookhart, M. Alan
    Hasegawa, Takeshi
    Kurokawa, Kiyoshi
    Fukuhara, Shunichi
    SCIENTIFIC REPORTS, 2016, 6
  • [45] REDUCED OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM TREATED WITH CINACALCET
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [46] PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
    Tadao Akizawa
    Noriaki Kurita
    Masahide Mizobuchi
    Masafumi Fukagawa
    Yoshihiro Onishi
    Takuhiro Yamaguchi
    Alan R. Ellis
    Shingo Fukuma
    M. Alan Brookhart
    Takeshi Hasegawa
    Kiyoshi Kurokawa
    Shunichi Fukuhara
    Scientific Reports, 6
  • [47] Interim Analysis of Paricalcitol vs. Cinacalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Multicenter, Randomized, Positive Controlled Study (PERMIT Study)
    Qiao, Yingjin
    Sun, Xiaoyan
    Liu, Xinyu
    Wang, Junxia
    Li, Jie
    Wang, Donghai
    Zhang, Huazhen
    Wang, Pei
    Liu, Zhangsuo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 210 - 210
  • [48] Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism
    Akiba, Takashi
    Akizawa, Tadao
    Tsukamoto, Yusuke
    Uchida, Eiji
    Iwasaki, Manabu
    Koshikawa, Shozo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (02) : 117 - 125
  • [49] INTRAVENOUS PARICALCITOL, ORAL CINACALCET OR COMBINATION OF BOTH AGENTS - EFFECTIVENESS OF DIFFERENT STRATEGIES OF SECONDARY HYPERPARATHYROIDISM TREATMENT IN HEMODIALYZED PATIENTS
    Zawierucha, Jacek
    Malyszko, Jolanta
    Malyszko, Jacek
    Prystacki, Tomasz
    Marcinkowski, Wojciech
    Dryl-Rydzynska, Teresa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [50] Paricalcitol in Hemodialysis Patients with Secondary Hyperparathyroidism: A Long-Term Case Report
    Chen, Haoxiong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 788 - 788
12345